April 2022 Performance

Talk about a rough start to the year… I’m just glad that I am surviving this turmoil without any significant blowups. I do have a blowup in Gingko Bioworks with another -29% decline in April, but I knew what I was getting myself into and this is a relatively small position. Ginkgo Bioworks is executing well so declines of this magnitude has no impact on my longer term view of this company. I’m very impressed to see how far this company has progressed from their initial pitch at Y Combinator. I’ll be very patient with Gingko Bioworks. This market correction has a little feel of the 2000 decline, but just a tiny version of that. Corrections are healthy for the market so this will eventually pass.

I’m currently not involved in any merger arb plays. I’m still selling out of the money Puts on some volatile tech stocks such as Tesla. The premium is nice, but it can get hairy very quickly. I’m playing much more conservatively by not leveraging up too much.

So just waiting for the market to stabilize before even considering buying anything. No need trying to catch a falling hatchet…

2022 Performance = -6.39% with the running monthly returns as follows:

January -0.68%

February -6.00%

March +4.89%